NVIV

InVivo Therapeutics Holdings Corp
NVIV

Overview Fund Activity
Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

46 hedge funds and large institutions have $3.04M invested in InVivo Therapeutics Holdings Corp in 2017 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 9 closing their positions.

Holders
46
Holders Change
-5
Holders Change %
-9.8%
% of All Funds
1.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
13
Closed
9
Calls
–
Puts
$3K
Net Calls
-$3K
Net Calls Change
+$22K

Top Buyers

1
ICM
1
IMS Capital Management
Oregon
$481K
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$56K
3
WS
3
Wedbush Securities
California
$76K
4
VF
4
Virtu Financial
New York
$32K
5
UBS Group
5
UBS Group
Switzerland
$58K

Top Sellers

1
WF
1
Welch & Forbes
Massachusetts
$78K
2
Millennium Management
2
Millennium Management
New York
$163K
3
ARTA
3
A.R.T. Advisors
New York
$0
4
Morgan Stanley
4
Morgan Stanley
New York
$115K
5
BBA
5
Baker Bros. Advisors
New York
$255K
Name Market Value Shares Shares
Change 		Shares
Change %
JCM
51
Jacobi Capital Management
Pennsylvania
$0 500 – –
CG
52
Cutler Group
California
$0 700 – –
Deutsche Bank
53
Deutsche Bank
Germany
$0 81 – –
Citigroup
54
Citigroup
New York
$0 500 – –
MSA
55
Marino Stram & Associates
Massachusetts
$0 38 +38 New
1 2
3